Synergy CHC Corp.
SNYRNasdaq
$0.19
↓ -4.6%Jul 17 close · end-of-day
Price
1Y↓ -94.6%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$2.1M
Enterprise Value
$26.8M
P/E
—
P/S
0.1
P/B
—
EV/EBITDA
—
PEG
—
FCF Yield
—
Dividend Yield
—
Revenue (TTM)
$27.7M
Net Income (TTM)
-$15.8M
Free Cash Flow (TTM)
—
Gross Margin
65.4%
Operating Margin
-39.6%
Net Margin
-57.0%
ROE
62.1%
ROIC
—
Debt / Equity
-1.0
Net Cash
-$24.7M
Return 1Y
-94.9%
Company profile
Synergy CHC Corp. provides consumer health care, beauty, and lifestyle products in the United States, Canada, and the United Kingdom. The company sells its products through retailers and television advertising campaigns.
- Sector
- Manufacturing
- Industry
- Pharmaceutical Products
- Employees
- 40
- Headquarters
- Maine
- Website
- www.synergychc.com
Earnings
SNYR Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$5.5M↓ -32.8%
Diluted EPS-$0.23↓ -330.0%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Revenue | — | $42.8M | $34.8M | $30.4M |
| Gross profit | — | $32.1M | $23.6M | $20.3M |
| Operating income | — | $10.8M | $5.8M | -$8.5M |
| Net income | — | $6.3M | $2.1M | -$12.3M |
| Diluted EPS | — | $0.86 | $0.28 | -$1.27 |
| Operating cash flow | — | $421,729.00 | -$4.8M | -$2.6M |
| Free cash flow | — | — | — | — |
| Gross margin | — | 75.0% | 67.9% | 66.8% |
| Operating margin | — | 25.3% | 16.7% | -27.8% |
| Net margin | — | 14.8% | 6.1% | -40.6% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $8.0M | $7.1M | $10.3M | $8.2M | $8.1M | $8.0M | $6.1M | $5.5M |
| Gross profit | $5.6M | $4.8M | $6.5M | $6.2M | $6.2M | $5.7M | $2.2M | $4.0M |
| Operating income | $1.6M | $1.1M | $1.4M | $1.9M | $1.6M | $1.3M | -$13.3M | -$567,120.00 |
| Net income | $655,186.00 | $783,593.00 | $105,667.00 | $876,264.00 | $1.5M | $125,327.00 | -$14.8M | -$2.6M |
| Diluted EPS | $0.09 | $0.11 | $0.00 | $0.10 | $0.17 | $0.01 | -$1.55 | -$0.23 |
| Operating cash flow | -$281,963.00 | -$237,474.00 | -$3.4M | -$822,781.00 | -$76,950.00 | -$2.3M | $624,127.00 | -$2.0M |
| Free cash flow | — | — | — | — | — | — | — | — |
| Gross margin | 69.5% | 67.2% | 63.3% | 75.4% | 76.7% | 70.9% | 36.6% | 72.3% |
| Operating margin | 19.7% | 14.7% | 13.2% | 23.8% | 20.0% | 16.0% | -219.5% | -10.3% |
| Net margin | 8.2% | 11.0% | 1.0% | 10.7% | 18.1% | 1.6% | -244.3% | -46.8% |
Company news
Jun 27, 2026
May 14, 2026
May 7, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
No insider transactions in the last 12 months.
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-04-21 | Kaushal Nitin | Award | 306,433 | $0.00 | $0.00 | filing |
| 2026-04-21 | Thompson Teresa Brigid | Award | 25,824 | $0.00 | $0.00 | filing |
| 2025-07-30 | Ross Jack· CEO and Chairman | Buy | 100 | $3.69 | $369.00 | filing |
| 2025-07-29 | Ross Jack· CEO and Chairman | Buy | 250 | $3.66 | $915.00 | filing |
| 2025-07-25 | Ross Jack· CEO and Chairman | Buy | 350 | $3.90 | $1,365.00 | filing |
| 2025-07-24 | Ross Jack· CEO and Chairman | Buy | 300 | $3.83 | $1,149.00 | filing |
| 2025-07-22 | Ross Jack· CEO and Chairman | Buy | 300 | $3.54 | $1,062.00 | filing |
| 2025-07-11 | Ross Jack· CEO and Chairman | Buy | 750 | $3.20 | $2,400.00 | filing |
| 2025-07-10 | Ross Jack· CEO and Chairman | Buy | 1,400 | $3.19 | $4,466.00 | filing |
| 2025-07-09 | Ross Jack· CEO and Chairman | Buy | 400 | $3.15 | $1,260.00 | filing |
| 2025-07-08 | Ross Jack· CEO and Chairman | Buy | 800 | $3.36 | $2,688.00 | filing |
| 2025-07-07 | Ross Jack· CEO and Chairman | Buy | 700 | $3.26 | $2,282.00 | filing |
| 2025-07-03 | Ross Jack· CEO and Chairman | Buy | 1,750 | $3.22 | $5,635.00 | filing |
| 2025-07-02 | Ross Jack· CEO and Chairman | Buy | 3,750 | $3.23 | $12,112.50 | filing |
| 2025-07-01 | Ross Jack· CEO and Chairman | Buy | 250 | $3.05 | $762.50 | filing |
| 2025-06-30 | Ross Jack· CEO and Chairman | Buy | 2,600 | $2.69 | $6,994.00 | filing |
| 2025-06-27 | Ross Jack· CEO and Chairman | Buy | 100 | $2.60 | $260.00 | filing |
| 2025-06-26 | Ross Jack· CEO and Chairman | Buy | 650 | $2.55 | $1,657.50 | filing |
| 2025-06-24 | Ross Jack· CEO and Chairman | Buy | 600 | $2.63 | $1,578.00 | filing |
| 2025-06-23 | Ross Jack· CEO and Chairman | Buy | 400 | $2.61 | $1,044.00 | filing |
| 2025-06-20 | Ross Jack· CEO and Chairman | Buy | 10,300 | $2.60 | $26,780.00 | filing |
| 2025-06-18 | Ross Jack· CEO and Chairman | Buy | 600 | $2.23 | $1,338.00 | filing |
| 2025-06-17 | Ross Jack· CEO and Chairman | Buy | 100 | $2.48 | $248.00 | filing |
| 2025-06-16 | Ross Jack· CEO and Chairman | Buy | 450 | $2.28 | $1,026.00 | filing |
Latest 24 transactions.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.